Stock & Company Details
Enlivex Therapeutics Ltd $ENLV
Price:
N/A
N/A
17M
$26M
52 Week High:
N/A
10 Day Average Volume:
N/A
0.01
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ENLV technical indicators
Latest Enlivex Therapeutics Ltd (ENLV) indicator readings as of 2026-08-28.
ENLV's 14-day RSI is 35.1, in neutral territory. At $1.35 it is trading 4.1% above its 200-day moving average of $1.30, and below its 50-day average of $2.39. Price sits near the lower Bollinger Band ($1.21 to $2.27). ADX reads 22.1, sitting between trending and range-bound.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
Finance Bot
Ask your questions
Start by typing a question below.
